ESOP18 Jul 2026, 05:00 pm
Rossari Biotech Grants 4000 Stock Options Under ESOP 2019
AI Summary
Rossari Biotech Ltd announced the grant of 4000 stock options under its Employee Stock Option Plan - 2019 (ESOP 2019) during a Board of Directors meeting held on July 18, 2026. The Board also approved the unaudited financial results for the quarter ended June 30, 2026, and the allotment of 2500 equity shares upon exercise of options. Additionally, the company approved the transfer of its 100% shareholding in Rossari International Limited Company to Rossari (Singapore) Pte. Ltd. as part of an internal restructuring.
Key Highlights
- Board approved grant of 4000 stock options under ESOP 2019.
- Unaudited financial results for Q1 FY27 were approved.
- 2500 equity shares allotted upon exercise of ESOP options.
- Internal restructuring involves transfer of subsidiary shareholding.
Price Impact
More from ROSSARI